Website works in test mode - Old version
Hotline 15 20 Hotline 15 20 Hotline 15 20

Representatives of the GCCA participated in the OECD-GVH RCC seminar on “Pharma Markets and Competition” in Budapest

Representatives of the Georgian Competition and Consumer Agency (GCCA), Mariam Berulava, Deputy Head of the Strategic Markets Monitoring Department, and Salome Kupatadze, Chief Specialist of the Economic Competition Department, participated in the international seminar entitled “Pharma Markets and Competition, organized by the OECD-GVH Regional Centre for Competition (OECD-GVH RCC).


The seminar convened competition authorities and sectoral experts to examine key competition law issues specific to pharmaceutical markets, regulatory frameworks and their practical implications, as well as enforcement tools and investigative approaches applied in this highly regulated sector. The discussions facilitated an exchange of institutional experience and best practices among participating jurisdictions. The event was attended by representatives of the European Commission, the UK Competition and Markets Authority, and competition authorities from Italy, Lithuania, Hungary and other countries.


Within the framework of the seminar, Mariam Berulava delivered a presentation entitled “Excessive Pricing in Pharmaceutical Markets - The Experience of the GCCA”. The presentation outlined the Agency’s enforcement practice, analytical methodologies, and legal instruments applied in assessing potential competition restrictions and unfair market conduct in pharmaceutical markets, with particular emphasis on excessive pricing assessments.


The OECD-GVH RCC is a joint initiative of the OECD and the Hungarian Competition Authority, established to strengthen competition policy frameworks and enforcement capacity in South-Eastern and Eastern Europe.


The Georgian Competition and Consumer Agency remains committed to advancing international cooperation and continuously enhancing institutional expertise, thereby contributing to the effective enforcement of competition rules and the protection of consumer interests in pharmaceutical and other strategically important markets.

04.03.2026
უკან დაბრუნება